Company registration number 03421879 (England and Wales)
EVERWELL CHINESE MEDICAL CENTRE LTD
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
EVERWELL CHINESE MEDICAL CENTRE LTD
COMPANY INFORMATION
Director
Mr G F Ren
Secretary
Dr H Sun
Company number
03421879
Registered office
7 Little Newport Street
London
WC2H 7JJ
Accountants
Xeinadin Billericay Limited
Lakeview House
4 Woodbrook Crescent
Billericay
Essex
CM12 0EQ
EVERWELL CHINESE MEDICAL CENTRE LTD
CONTENTS
Page
Director's report
1
Accountants' report
2
Balance sheet
3
Notes to the financial statements
4 - 6
EVERWELL CHINESE MEDICAL CENTRE LTD
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 OCTOBER 2025
- 1 -

The director presents his annual report and financial statements for the year ended 31 October 2025.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

Mr G F Ren
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mr G F Ren
Director
13 August 2026
EVERWELL CHINESE MEDICAL CENTRE LTD
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF EVERWELL CHINESE MEDICAL CENTRE LTD FOR THE YEAR ENDED 31 OCTOBER 2025
- 2 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Everwell Chinese Medical Centre Ltd for the year ended 31 October 2025 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the b oard of d irectors of Everwell Chinese Medical Centre Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Everwell Chinese Medical Centre Ltd and state those matters that we have agreed to state to the b oard of d irectors of Everwell Chinese Medical Centre Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Everwell Chinese Medical Centre Ltd and its b oard of d irectors as a body, for our work or for this report.

It is your duty to ensure that Everwell Chinese Medical Centre Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Everwell Chinese Medical Centre Ltd. You consider that Everwell Chinese Medical Centre Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Everwell Chinese Medical Centre Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory f inancial statements.

Xeinadin Billericay Limited
Lakeview House
4 Woodbrook Crescent
Billericay
Essex
CM12 0EQ
13 August 2026
EVERWELL CHINESE MEDICAL CENTRE LTD
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 3 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
64,387
50,868
Current assets
Stocks
165,175
157,743
Debtors
69,171
17,476
Cash at bank and in hand
327,205
328,091
561,551
503,310
Creditors: amounts falling due within one year
(287,281)
(274,710)
Net current assets
274,270
228,600
Net assets
338,657
279,468
Capital and reserves
Called up share capital
5
100
100
Profit and loss reserves
338,557
279,368
Total equity
338,657
279,468

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 13 August 2026
Mr G F Ren
Director
Company registration number 03421879 (England and Wales)
EVERWELL CHINESE MEDICAL CENTRE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 4 -
1
Accounting policies
Company information

Everwell Chinese Medical Centre Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 7 Little Newport Street, London, WC2H 7JJ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is nine years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

EVERWELL CHINESE MEDICAL CENTRE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 5 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
12.5% on cost
Leasehold improvements
12.5% on cost
Fixtures and fittings
25% on reducing balance
Computers
33% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.7
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
28
32
EVERWELL CHINESE MEDICAL CENTRE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 6 -
3
Intangible fixed assets
Total
£
Cost
At 1 November 2024 and 31 October 2025
166,000
Amortisation and impairment
At 1 November 2024 and 31 October 2025
166,000
Carrying amount
At 31 October 2025
-
0
At 31 October 2024
-
0
4
Tangible fixed assets
Leasehold land and buildings
Leasehold improvements
Fixtures and fittings
Computers
Total
£
£
£
£
£
Cost
At 1 November 2024
60,831
50,591
69,577
16,125
197,124
Additions
-
0
-
0
45,428
1,614
47,042
Disposals
-
0
-
0
(38,209)
(9,998)
(48,207)
At 31 October 2025
60,831
50,591
76,796
7,741
195,959
Depreciation and impairment
At 1 November 2024
53,612
46,872
34,885
10,887
146,256
Depreciation charged in the year
1,031
3,717
9,199
2,554
16,501
Eliminated in respect of disposals
-
0
-
0
(22,651)
(8,534)
(31,185)
At 31 October 2025
54,643
50,589
21,433
4,907
131,572
Carrying amount
At 31 October 2025
6,188
2
55,363
2,834
64,387
At 31 October 2024
7,219
3,719
34,692
5,238
50,868
5
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100
2025-10-31 2024-11-01 false false false 13 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr G F Ren Dr H Sun 03421879 2024-11-01 2025-10-31 03421879 bus:Director1 2024-11-01 2025-10-31 03421879 bus:CompanySecretary1 2024-11-01 2025-10-31 03421879 bus:RegisteredOffice 2024-11-01 2025-10-31 03421879 2025-10-31 03421879 2024-10-31 03421879 core:LandBuildings 2025-10-31 03421879 core:LeaseholdImprovements 2025-10-31 03421879 core:FurnitureFittings 2025-10-31 03421879 core:ComputerEquipment 2025-10-31 03421879 core:LandBuildings 2024-10-31 03421879 core:LeaseholdImprovements 2024-10-31 03421879 core:FurnitureFittings 2024-10-31 03421879 core:ComputerEquipment 2024-10-31 03421879 core:WithinOneYear 2025-10-31 03421879 core:WithinOneYear 2024-10-31 03421879 core:ShareCapital 2025-10-31 03421879 core:ShareCapital 2024-10-31 03421879 core:RetainedEarningsAccumulatedLosses 2025-10-31 03421879 core:RetainedEarningsAccumulatedLosses 2024-10-31 03421879 core:ShareCapitalOrdinaryShareClass1 2025-10-31 03421879 core:ShareCapitalOrdinaryShareClass1 2024-10-31 03421879 core:Goodwill 2024-11-01 2025-10-31 03421879 core:LandBuildings core:LongLeaseholdAssets 2024-11-01 2025-10-31 03421879 core:LeaseholdImprovements 2024-11-01 2025-10-31 03421879 core:FurnitureFittings 2024-11-01 2025-10-31 03421879 core:ComputerEquipment 2024-11-01 2025-10-31 03421879 2023-11-01 2024-10-31 03421879 2024-10-31 03421879 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-10-31 03421879 core:LeaseholdImprovements 2024-10-31 03421879 core:FurnitureFittings 2024-10-31 03421879 core:ComputerEquipment 2024-10-31 03421879 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-10-31 03421879 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-11-01 2025-10-31 03421879 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 03421879 bus:OrdinaryShareClass1 2025-10-31 03421879 bus:OrdinaryShareClass1 2024-10-31 03421879 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 03421879 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 03421879 bus:FRS102 2024-11-01 2025-10-31 03421879 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 03421879 bus:FullAccounts 2024-11-01 2025-10-31 xbrli:pure xbrli:shares iso4217:GBP